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INTRODUCTION
Alexithymia was introduced conceptually in 1970 and defined as alienation to self feelings; difficulty in describing, identifying, and expressing 
feelings; or a decrease in the capacity and potential to identify and verbalize emotions due to deficits or limitations in the cognitive process-
ing (1,2,3,4,5,6). Two components of alexithymia are defined, one of them is the affective component characterized by reduced emotional 
awareness and the other is cognitive component characterized by operational thinking style (7,8,9). After the construct of alexithymia was 
introduced, various studies have been conducted to show the deficiency in people, negative impact on interpersonal relations and its associ-
ation with physical and mental health problems (10,11,12).
Developmental, genetic, social learning, psychoanalytic, neurophyslogical, neurobiological, and/or neuropsychological approaches are import-
ant in explaining the etymology of the construct (2,13,14,15,16,17,18,19,21,22,23,24).
Many models have been proposed to neurobiologically or neuropychologically explain alexithymia. The right hemisphere is used more in 
processing nonverbal, unconscious, and emotional information compared to the left hemisphere, which predominately processes conscious 
and verbal information (25). In line with this information, two different widely accepted neurobiological explanations are formulated. The 
first explanation states that the information sent to the left hemisphere from the right hemisphere is at the corpus callosum, or there is an 
interhemispheric transfer deficit at the limbic system and between the two hemispheres. The second explanation states that dysfunction of 
the cortex of the right hemisphere causes alexithymia (22,26,27).
According to the psychoanalytic approach, alexithymia is related to defense mechanisms, or it is a defense mechanism against anxiety, conflict, 
and trauma states that causes discomfort or a style to cope with stress (28,29,30,31). Alexithymia scores have been found to stay quite stable 
over long periods in various longitudinal studies in clinical and nonclinical samples. Based on these findings, recently alexithymia as a person-
ality characteristic has gained wide acceptance (32,33,34,35,36). For this reason, it has been reported that alexithymia is a characteristic or a 
construct showing normal distribution in a general sample (4,37,38). Alexithymia is not only related to an individual’s emotions but also alex-
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Introduction: It is not clear in the literature whether available instruments 
are sufficient to measure alexithymia because of its theoretical structure. 
Moreover, it has been reported that several measuring instruments are 
needed to measure this construct, and all the instruments have different 
error sources. The old and the new forms of Toronto Alexithymia Scale 
are the only instruments available in Turkish. Thus, the purpose of this 
study was to develop a new scale to measure alexithymia, selecting items 
and constructing the factor structure.
Methods: A total of 1117 patients aged from 19 to 82 years (mean 
= 35.05 years) were included. A 100-item pool was prepared and 
applied to 628 women and 489 men. Data were analyzed using 
Explanatory Factor Analysis, Confirmatory Factor Analysis, and Item 
Response Theory and 28 items were selected. The new form of 28 
items was applied to 415 university students, including 271 women 
and 144 men aged from 18 to 30 (mean=21.44).
Results: The results of Explanatory Factor Analysis revealed a five-
factor construct of "Solving and Expressing Affective Experiences,” 
"External Locused Cognitive Style,” "Tendency to Somatize Affections,” 
"Imaginary Life and Visualization,” and "Acting Impulsively,” along with 
a two-factor construct representing the "Affective” and "Cognitive” 
components. All the components of the construct showed good 
model fit and high internal consistency. The new form was tested in 
terms of internal consistency, test-retest reliability, and concurrent 
validity using Toronto Alexithymia Scale as criteria and discriminative 
validity using Five-Factor Personality Inventory Short Form.
Conclusion: The results showed that the new scale met the basic 
psychometric requirements. Results have been discussed in line with 
related studies.
Keywords: Alexithymia, alexithymia scale, affective, cognitive
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ithymics exhibit deficits and disabilities in understanding and relating to the 
emotions of others (9,39). Thus, it has been emphasized that alexithymics 
have impaired capacity for empathy (40,41,42).
It has been shown that alexithymia is not a psychiatric diagnostic category 
by itself; it rather contributes to psychosomatic or psychiatric disorders. 
The prevalence of alexithymia varies in various groups due to different 
measuring instruments and their cut off points (43,44). In different studies, 
the prevalence in a general sample changes from 7.1% to 17.0% (45,46). 
Alexithymia has been reported as a risk factor for physical and mental 
health (19,47,48,49). An increasing number of clinical and experimental 
studies have associated this construct with various physical and mental 
disorders (50,51).
It has been shown that alexithymia is associated with anxiety, depres-
sion, and major depression in both general and clinical samples but 
not highly correlated (52,53,54,55,56). Similarly, many studies have re-
ported associations between this construct and state and trait anxiety, 
post-traumatic stress disorder, psychopathology, and personality disorders 
(57,58,59,60,61). It is important to understand the relationship between 
the construct and the disorders to control the risk factors and thus pre-
vent the disorders (4,50).
Measurement of Alexithymia
The efforts to measure alexithymia appear to begin with Beth Israel Hos-
pital Questionnaire, and it is rated by a clinician/observer (3). Other tests 
rated by observers are the Alexithymia-Provoked Response Question-
naire, the Karolinska Psychodynamic Profile based on psychoanalytic the-
ory that composes one of the subdimensions of alexithymia, California 
Q-set Alexithymia Prototype, Observer Alexithymia Scale which is the 
revised form of the previous scale, and the Toronto Structured Inter-
view for Alexithymia (62,63,64,65,66,67,68,69,70,71,72). In regard to the 
projective forms, one of them is the Objectively Scored Archetypal Test 
(73,74,75). Another one is the Rorschach Alexithymia Scale, which is de-
veloped to predict scores of the Toronto Alexithymia Scale (TAS) Revised 
Form Three using marker variables from the Rorschach system (76,77).
The self-report forms include the MMPI Alexithymia Scale, whose items 
were selected from the MMPI, Schalling-Sifneos Personality Scale, Am-
sterdam Alexithymia Scale, Bermond-Vorst Alexithymia Test, which is the 
revised form of the previous scale, and psychological Treatment Invento-
ry-Alexithymia Scale (78,79,80,81,82). TAS has been found to have good 
psychometric qualities and to be the most widely used self-report scale 
(83). The first form of TAS was developed as a 26-item and four subdi-
mensions’ self-report scale (74,84,85). In the first revision of the scale, 
items have been reduced to 23 and subdimensions to two (86). The sec-
ond revision and the third form of the scale have been reorganized to 
have 20 items and three facets (87).
In addition, there are scales developed to measure alexithymia in children 
and adolescents. The Alexithymia Observation Scale for Children, two 
revisions of TAS for children, which are called TAS for Children, the Emo-
tional Awareness Questionnaire for Children, and the revised form of this 
scale are the tests developed for this group (88,89,90,91,92).
Alexithymia as a multidimensional construct and it is questionable wheth-
er a single measurement or a measuring instrument will be sufficient to 
measure this construct; thus, it is reported that much more instruments 
are needed. Moreover, existing measuring instruments have different er-
ror sources (93). Measuring instruments in Turkish are the two forms of 
TAS, 26-item first form and 20-item third form (94,95). Accordingly, with 
the aim of developing a new measuring instrument for alexithymia, the 
procedures of item selection, creation of its factor structure, and develop-
ing a new form were conducted, and the new form was tested for internal 
consistency, test-retest reliability, criterion-related validity and discriminant 
validity.
METHODS
Creation of Item Pool
Firstly, considering the components of the construct and items in the sim-
ilar scales, 110 items were written. The number of items were then re-
duced to 100; after scrutiny and corrections were made, these items were 
used in the first administration of the scale. Ratings were created using a 
five-point Likert scale ranging from “always” (1) to “never” (5).
Participants
Participants in the first administration (A1): In the first ad-
ministration, participants consisted of 628 women (56.2%) and 489 
men (43.8%) from a total of 1117 individuals aged from 19 to 82 years 
(mean=35.05±11.49 years). Students were not included in this admin-
istration. The participants consisted of 451 single (40.4%), 625 married 
(56.0%), 24 divorced (2.1%), 17 widowed (1.5%), and 3 individuals with 
unknown marital status (0.1%). The education level was as follows: 135 
primary school graduates (12.1%), 117 middle school graduates (10.5%), 
286 high school graduates (25.6%), 576 bachelors (51.6%), and 3 indi-
viduals with unknown education status (0.3%). The income level was as 
follows: 67 people defined income as poor (6.0%), 756 as middle (67.7%), 
255 as good (22.8%), and 39 people did not specify the income level 
(3.5%).
Participants in the second administration (A2): Participants 
consisted of 271 women (65.3%) and 144 men (34.7%) from a total 
of 415 undergraduate and postgraduate students from different facul-
ties and universities aged between 18 and 30 years (mean=21.44±1.49 
years). Out of these participants, 117 students aged between 18 and 25 
years (mean=21.24±1.32 years) participated in the discriminant validity 
study, 50 students aged between 20 and 27 years (mean=21.86±1.33 
years) participated in the criterion-related validity study, and 48 students 
aged between 20 and 25 years (mean=21.73±1.11 years) participated in 
test-retest study.
Procedure
After the approval from the ethic committee of Fatih Sultan Mehmet (FSM) 
Vakıf University was received, two separate administrations were made in 
two semesters in Istanbul. Participants were determined using the conve-
nience sampling method and voluntarily accepting to participate in the study. 
“Informed consent” was obtained from the participants of the study. The 
prepared forms were administered individually and answered as a self-re-
port. In the first administration (A1), pool items and sociodemographic 
questions were completed. The second administration (A2) was made with 
the revised form of 28 items using a five-point Likert scale. TAS-20 was used 
to determine the criterion-related validity, and the Five-Factor Personality 
Inventory (5FPI) was used for the discriminant validity in this administration. 
Furthermore, 15 days after the second administration test, a retest study 
was conducted. In both administrations, besides the tests given, age, gender, 
education level, marital status, and income level information was collected 
to identify participant characteristics.
Data Collection Tools
The Toronto Alexithymia Scale
TAS-20 is a self-report scale using the five-point, Likert-type answering 
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options. It assesses three dimensions of alexithymia: difficulty identifying 
feelings (DIF), difficulty describing feelings (DDF), and externally oriented 
thinking (EOT) and gives a total score (TS) (95).
The Five-Factor Personality Inventory
The 5FPI comprises of 220 items answered on a five-point Likert scale; 
it assesses five factors and 17 subdimensions (96). In this study, the short 
form of the inventory that assesses five factors, namely Extraversion (E), 
Agreeableness (A), Conscientiousness (C), Emotional Stability (ES), and 
Openness to Experience (OE) were used (97).
Statistical Analysis
In this study for the calculations of internal consistency reliability and 
test-retest reliability Statistical Package for Social Sciences 21.0 (IBM 
Corp.; Armonk, NY, USA) programe, for the confirmatory factor analysis 
(CFA) Amos 21.0 (IBM Corp.; Meadville, PA, USA) programe and for the 
analysis of Item Response Theory (IRT) Parscale 4.1 (Scientific Software 
International, Inc., Skokie, IL, USA) programe were used.
RESULTS
Item Selection Procedure
Item selection process, Explanatory Factor Analysis (EFA), and assessment 
of parameters by Item Response Theory (IRT) were conducted in an in-
terweaved manner in this study. Firstly, the items were examined with 
EFA, and the emerging factors were named according to item contents. 
Every factor was examined in its right, and the item loadings below 0.30 
or items that were located in more than one factor with similar loadings to 
Table 1. Five-Factor explanatory factor analysis results of the A Alexithymia Scale in first and second administration
                 SEEE                   EOCS                  TSE                   ILI                  AI
Items A1 A2 A1 A2 A1 A2 A1 A2 A1 A2
Item 98 0.68 0.78        
Item 100 0.66 0.57  0.29      0.22
Item 12 0.66 0.75        
Item 52 0.64 0.76        
Item 38 0.62 0.65  0.27     0.25 
Item 32 0.62 0.67        
Item 36 0.55 0.46    0.32    
Item 13 0.54 0.45        
Item 41 0.52 0.54  0.28     0.23 0.20
Item 86 0.48 0.41        
Item 91  0.25 0.70 0.65      
Item 75   0.69 0.74      
Item 49   0.66 0.61      
Item 39 0.24 0.22 0.56 0.55      
Item 72   0.54 0.57  0.26    
Item 78     0.72 0.80   0.23 0.23
Item 55     0.69 0.81   0.27 0.21
Item 94     0.60 0.42    -0.31
Item 45     0.58 0.58    -0.31
Item 51  0.22   0.46 0.33    -0.29
Item 22 0.31 0.28   0.44 0.49    
Item 14       0.81 0.85  
Item 2       0.78 0.81  
Item 60       0.74 0.76  
Item 18         0.75 0.66
Item 8         0.69 0.61
Item 31 0.36 0.22       0.49 0.55
Item 6 0.22        0.48 0.59
Eigen values 5.16 5.63 2.58 1.85 1.73 2.88 1.62 1.53 1.35 1.40
Percentage of variance 18.44 20.10 9.21 6.60 6.16 10.27 5.78 5.48 4.83 4.99
Cumulative % 18.44 20.10 27.65 26.70 33.81 36.97 39.59 42.45 44.42 47.44
*Loading values below 0.20 were excluded
SEEE: solving and expressing emotional experiences; EOCS: externally oriented cognitive style; TSE: tendency to somatosize emotions; ILI: imaginary life and imagina-
tion; AI: acting impulsively; A1: first administration; A2: second administration
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each other were excluded. Subsequently, the items in a factor were exam-
ined by an item analysis. Firstly, the items that raised the reliability in case of 
removal and then the items that showed item TS correlations below 0.30 
were removed. In addition, the items in every factor and in the whole scale 
were separately examined using IRT. Using the two parameters logistic 
model (2PLM), item discrimination (a) and item difficulty (b) were calcu-
lated. At this stage, items with low-discrimination were removed, and the 
number of items functioning at low-high alexithymia levels were attempt-
ed to balance. All processes were performed repeatedly and the items 
were removed/selected gradually. At every stage, the construct obtained 
was tested using factor analysis to understand whether it is protected. At 
the last stage, the number of items selected was reduced to 28.
Validity Study
Exploratory factor analysis and construct validity results
All possible EFA solutions from a single factor to seven factors were exam-
ined in the A1 item selection process. Results showed that the most appro-
priate solution that coincides with the theoretical construct was the five-fac-
tor construct. It was observed that the data are suitable for factor analysis 
(Kaiser-Meyer-Olkin (KMO)=0.858; Bartlett χ2 (378)=6437.09; p<0.001), 
and the five-factor construct explained 44.42% of the total variance. The 
distribution of the selected 28 items located in the five-factor solution 
was protected exactly in the six- and seven-factor solutions. Out of the 
factors located in the five-factor solution, two or three combined and pre-
served exactly in the two-factor solution. Considering the factor content, 
the five-factor solution of the construct was named as follows: Solving and 
Expressing Emotional Experiences (SEEE; e.g., I have difficulty in describing 
my feelings. I have difficulty in expressing my feelings); Externally Oriented 
Cognitive Style (EOCS; e.g., I solve daily problems successfully); Tendency 
to Somatosize Emotions (TSE) emphasizing cognitive processes instead of 
expressing feelings (e.g., it is unnecessary to explain emotions), Imaginary 
Life and Imagination (ILI; e.g., I love daydreaming); and Acting Impulsively (AI; 
e.g., I give immediate reactions to events) (Table 1).
In two-factor solutions, when SEEE and AI factors are combined, they 
create Emotional Component (EC) of the construct (e.g., I have difficulty 
in expressing my feelings); when EOCS, ILI, and TSE are combined, they 
create Cognitive Component (CC) of the construct (e.g., It is unnecessary 
to describe feelings). When the factor items of EC and CC are examined 
separately using EFA, subdimensions are differentiated as in the case when 
they are combined. The two-factor construct explained 27.65% of the 
total variance. Thus, the construct, in accordance with literature, has two 
stages with EC and CC components in the first level, and the second level 
with five factors are underneath this upper construct (Table 2).
It was noted that the data obtained in A2 were satisfactory for factor 
analysis (KMO=0.826; Bartlett χ2 (378)=3201.44; p<0.001); factor load-
ings for both two- and five-factor solutions obtained in A1 were retained 
exactly, except for small differences. While five-factor solutions explained 
47.44% of the total variance, two-factor solutions explained 30.37% of the 
total variance (Table 1, 2).
Construct validity with confirmatory factor analysis
All the factor solutions obtained using the EFA analysis were examined 
additionally by confirmatory factor analysis (CFA) for A1 and A2 data. The 
most appropriate-fit values were obtained for the second-level five-factor 
construct under the EC and CC first-level construct (Figure 1). The re-
sults of A1 and A2 and the results of two- and five-factor solutions were 
close to each other according to the obtained values (Table 3). When all 
results were evaluated as a whole, GFI, AGFI, and RMR were at good fit, 
RMSEA and χ2/sd ratios were slightly over the acceptable fit, and CFI and 
NFI were below acceptable fit level (98).























Table 2. First and second administration two-factor explanatory factor 
analysis results of A Alexithymia Scale
                 EC                  CC
Items A1 A2 A1 A2
Item 38 0.65 0.67  
Item 52 0.65 0.69  
Item 98 0.65 0.70  
Item 100 0.62 0.67  
Item 32 0.58 0.63  0.23
Item 41 0.58 0.63  
Item 12 0.57 0.66  
Item 36 0.51 0.50  0.21
Item 31 0.50 0.44  
Item 13 0.50 0.41  
Item 86 0.48 0.47  
Item 6 0.44 0.38  -0.33
Item 8 0.43 0.38  -0.30
Item 18 0.41 0.40  
Item 39 0.26  0.32 0.45
Item 78  0.30 0.57 0.55
Item 55 0.24 0.23 0.54 0.55
Item 60   0.52 0.55
Item 94   0.52 0.50
Item 14 -0.27  0.52 0.66
Item 51   0.47 0.37
Item 2 -0.25  0.46 0.59
Item 75 0.27  0.41 0.43
Item 72 0.22 0.33 0.39 0.33
Item 49   0.38 0.37
Item 45   0.37 0.49
Item 22  0.27 0.36 0.39
Item 91 0.24  0.32 0.45
Eigen values 5.16 5.63 2.58 2.88
Percentage of variance 18.44 20.10 9.21 10.27
Cumulative % 18.44 20.10 27.65 30.37
*Loading values below 0.20 were excluded
EC: emotional component; CC: cognitive component; A1: first administration; 
A2: second administration
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Criterion-related validity
The comparison of the total scores of TAS-20 and A Alexithymia Scale 
showed a correlation coefficient of 0.70. The first-factor SEEE in five-fac-
tor solutions are represented in TAS-20 in two separate dimensions. This 
factor showed a correlation coefficient of 0.67 with the DIF dimension 
and a correlation coefficient of 0.79 with the DDF dimension of TAS-20. 
In two-factor solutions, EC showed a correlation coefficient of 0.70 with 
the DIF dimension and 0.80 with the DDF dimension of TAS-20. Another 
common construct in both scales was the EOCS dimension in five-factor 
solutions and the EOT dimension in TAS-20. A correlation coefficient of 
0.11 was calculated between these factors of the two scales. However, in 
two-factor solutions CC showed a higher correlation coefficient (0.34) 
with the EOT dimension of TAS-20 (Table 4).
Discriminant validity
When A Alexithymia Scale was compared with 5FPI, the correlation co-
efficients of SEEE factor with E; EOCS factor with A, C, and ES; and AI 
factor with A and ES were over 0.30. The correlation coefficient between 
5FPI and ES ranged between 0.14 and 0.37, and it was between 0.12 and 
-0.40 for CC. The correlation coefficients between the TS of Alexithymia 
and personality inventory factors ranged between -0.29 and -0.35. The 
results showed that in terms of discriminant validity, the correlations be-
tween the alexithymia scale developed based on the trait approach model, 
and the constructs of personality factors were generally in the expected 
direction and at a level that would not overlap with each other (Table 4).
Reliability Study
Internal consistency reliability
For the components of five- and two-factor solutions related to A1 and 
A2, Cronbach Alpha internal consistency coefficients were calculated and 
reported in Table 5. Results showed that in the A1 internal consistency coef-
ficient for five factor was between 0.59 and 0.83, for EC and CC were 0.83 
and 0.69, respectively, for the whole scale, it was 0.81. In A2, the internal 
consistency coefficients were as follows: between 0.62 and 0.84 for five fac-
tor; 0.83 and 0.70 for EC and CC, respectively; and 0.82 for the whole scale.
Test-retest reliability
In test-retest reliability study, Pearson correlation coefficients were be-
tween 0.64 and 0.86 for the factors of five-factor solutions, were 0.85 for 
EC and 0.84 for CC for two-factor solutions, and was 0.87 for the whole 
scale (Table 5).
Table 3. First and second administration confirmatory factor analysis results of A Alexithymia Scale
                                     First administration                                     Second administration
 Five-factor  Two-factor  Five-factor  Two-factor  
Model fit summary solution solution solution solution
χ2 50.44 37.77 34.26 33.49
df 5 4 5 4
p 0.000 0.000 0.000 0.000
χ2/df 10.09 9.44 6.85 8.37
Goodness-of-Fit Index (GFI) 0.98 0.99 0.97 0.97
Adjusted Goodness-of-Fit Index (AGFI) 0.95 0.95 0.90 0.88
Confirmatory Fit Index (CFI) 0.82 0.87 0.73 0.73
Normed Fit Index (NFI) 0.81 0.86 0.71 0.72
Root mean squared residual (RMR) 0.05 0.04 0.07 0.07
Root mean square error of approximation (RMSEA) 0.09 0.09 0.12 0.13
χ2: Pearson Chi-Square Tests; df: degrees of freedom 
Table 4. Correlation Coefficients of A Alexithymia Scale with Toronto Alexithymia Scale-20 and five-factor personality inventory
            Toronto Alexithymia Scale-20 (n=48)  Five-Factor Personality Inventory (n=117)
Solutions  TS DIF DDF EOT E A C ES OE
Five factor solution SEEE 0.65*** 0.67*** 0.79*** 0.20 -0.40*** -0.13 -0.13 0.26** -0.21*
 EOCS 0.50*** 0.60*** 0.54*** 0.11 -0.14 -0.32*** -0.41*** 0.46*** -0.23*
 TSE 0.33* 0.23 0.37** 0.29* -0.17 -0.29** -0.25** -0.17 -0.25**
 ILI -0.09 -0.14 -0.19 0.11 -0.02 0.13 -0.02 0.00 -0.06
 AI 0.40** 0.48*** 0.47*** 0.05 -0.01 -0.36*** -0.09 0.40*** -0.03
Two-factor solution EC 0.66*** 0.70*** 0.80*** 0.18 -0.32*** -0.25** -0.14 0.37*** -0.18*
 CC 0.46*** 0.39** 0.47*** 0.34** -0.20* -0.32*** -0.40*** 0.12 -0.31**
A Alexithymia Scale TS 0.70*** 0.70*** 0.81*** 0.27 -0.34*** -0.35*** -0.30** 0.34*** -0.29**
*p<0.05; **p<0.01; ***p<0.001
TS: total score; DIF: difficulty identifying feelings; DDF: difficulty describing feelings; EOT: externally oriented thinking; E: extraversion; A: agreeableness; C: conscien-
tiousness; ES: emotional stability; OE: openness to experience; SEEE: solving and expressing emotional experiences; EOCS: externally oriented cognitive style; TSE: 
tendency to somatosize emotions; ILI: imaginary life and imagination; AI: acting impulsively; EC: emotional component; CC: cognitive component
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DISCUSSION
Different models and approaches have been suggested to evaluate alex-
ithymia in literature (11,69,81,82). The multidimensional construct of 
alexithymia creates difficulties in measurement (50). The need for new 
measuring instruments and different kind of error sources of the existing 
instruments have been reported (93). Also, an increasing number of stud-
ies emphasize that alexithymia is a personality trait (31). Instruments mea-
suring alexithymia are quite few in Turkish and the existing ones (TAS-26, 
TAS-20) are relatively old (74,87). Besides, there are many recent studies 
on the subject. Thus, this study was conducted considering the critics to-
ward existing instruments.
Alexithymia is characterized by weak imaginary life, weak empathy level, 
impulsive actions and tendency of somatosizing feelings, difficulty in de-
coding emotional messages, emotion expression, emotional experiences, 
externally oriented cognitive style, social adaptation, avoidance of conflict, 
being cold, independent, disturbances due to emotional changes in close 
relations (10,50,99,100). EFA results revealed that the factors of the con-
struct were solving and expressing emotional experiences, externally ori-
enting cognitive style, somatosizing emotions tendency, having imaginary 
life and imagination, and acting impulsively.
Although factor analytic studies, especially those on TAS, showed descrip-
tion and expression of emotions as separate constructs, this distinction 
was not observed in this study. None of the seven separate solutions from 
one to seven on A1 data differentiated in describing emotional experienc-
es (I have difficulty in describing my feelings) and expressing emotions (I 
have difficulty in expressing my feelings). No differentiation was observed 
even when a two-factor solution was applied only to the items of this 
factor. Furthermore, this situation is realized similarly for both expressions 
regarding self (I don’t know how I feel in an event or situation) and for 
expressions about others (I have difficulty in understanding the feelings 
of others).
Explanatory factor analysis results showed two components in alexithy-
mia, emotional and cognitive as previously shown in many languages/cul-
tures (7,8). In the studies where TAS-23 was developed, it was observed 
that the two-factor construct explained 25.1% (86) of the variance; in 
the studies where TAS-20 was developed, the three-factor construct ex-
plained 31% (87) of the variance. In the study where TAS-20 was adapt-
ed into Turkish, the two factors obtained explained 34.9% of the total 
variance (95). These values do not appear different from the results of 
two-factor solutions of 27.65% and 30.37%, respectively. The values are 
higher in five-factor solutions, 44.42% and 47.44%, respectively. Consid-
ering the variance explained when TAS-20 was developed and the vari-
ance of the scale adapted into Turkish, it appears that more than 10% 
incremental validity is obtained in this study. The result obtained in this 
study showed that the measurement level of the TAS-20 Turkish form 
was improved and even moved beyond it. Furthermore, the two- and 
five-factor solutions of the scale in this study seem as to provide a ben-
efit in practice. When different results of different scales are compared, 
two- and five-factor constructs of this newly developed scale will provide 
convenience in comparison.
Results of CFA indicate good fit and appear to be a slightly better than 
the values of similar studies. Also, results show that basic qualifications of 
former studies have been captured. The first sample of the study where 
TAS-20 was developed, GFI was 0.89, AGFI was 0.86, and RMSEA was 
0.07. For the second sample GFI was 0.86, AGFI was 0.83, and RMSEA 
was 0.07 (87). In the adaptation study of TAS-20 into Turkish, GFI was 
0.87, AGFI was 0.84, RMSEA was 0.08 (95). In this study, for the two-fac-
tor solution in A1, GFI was 0.99, AGFI was 0.95, and RMSEA was 0.09; 
for the five-factor solution, GFI was 0.98, AGFI was 0.95, and RMSEA was 
0.09. Values obtained for A2 were at a similar level.
In this study, for the whole scale, internal consistency coefficients obtained 
for A1 and A2 studies were 0.81 and 0.82, respectively. The study where 
TAS-20 was developed revealed internal consistency coefficients of 0.81 
in the first administration, 0.80 in the second student administration, and 
0.83 for the patient group for the whole scale (87). This value was found 
to be 0.78 in the adaptation study of TAS-20 into Turkish for the whole 
scale (95). Results are generally at a similar level in both two- and five-fac-
tor solutions. In contrast, although the A1 group was heterogeneous, A2 
was homogeneous and it had fewer participants; internal consistency val-
ues obtained were very close to each other. Moreover, similar values had 
been achieved in two- and five-factor solutions in both groups, thereby 
showing stability of the scale. However, considering that the number of 
items is small for ILI and the internal consistency coefficient for AI is lower 
than that for the other factors, these factors of the scale need strength-
ening in further studies.
The results of test-retest study conducted at an interval of 15 days were 
well within the acceptable levels. Correlation coefficients were 0.87 for 
the whole scale, 0.85 for EC, and 0.84 for CC. This coefficient was stated 
as 0.77 in the study of the development of TAS-20 (87). This coefficient 
was reported as 0.75 and 0.82 for the Rorschach Alexithymia Scale (76). 
Table 5. For first and second administration internal consistency coefficients of A Alexithymia Scale
   First administration  Second administration  Test-retest  
Solutions  k  (n=1117)  (n=415)  (n=50)
Five-factor solution SEEE 10 0.83 0.84 0.85***
 EOCS 5 0.66 0.67 0.64***
 TSE 6 0.64 0.67 0.86***
 ILI 3 0.71 0.76 0.73***
 AI 4 0.59 0.62 0.76***
Two-factor solution EC 14 0.83 0.83 0.85***
 CC 14 0.69 0.70 0.84***
A Alexithymia Scale TS 28 0.81 0.82 0.87***
***p<0.001
k: item number; SEEE: solving and expressing emotional experiences; EOCS: externally oriented cognitive style; TSE: tendency to somatosize emotions; ILI: imaginary 
life and imagination; AI: acting impulsively; EC: emotional component; CC: cognitive component; TS: total score
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Test-retest correlation coefficients for the five factor of this study were 
between 0.64 and 0.86, and in general, the dimensions of the scale showed 
high correlations that could be called stable against changes over time.
In the criterion-related validity study, correlation coefficients between 
TAS-20 and the total and five-factor scores of the A Alexithymia Scale 
were at an acceptably good level. Correlation coefficients were higher in a 
two-factor solution. At this stage, the problem is that while the correlation 
coefficient between the “EOCS” factor and the two dimensions and the 
TS of TAS-20 was at a high level, the correlation coefficient with the EOT 
dimension of TAS-20 was 0.11. It is clear that these two constructs are 
incompatible. In contrast, correlations with the other dimensions and the 
TS of TAS-20 and the results of EFA and CFA show that the construct 
named “EOCS” is a part of alexithymia. If the contents are examined, a 
great difference between the EOT items of TAS-20 (e.g., I’d prefer to re-
solve the problems rather than defining them) and the EOCS items (e.g., 
I solve daily problems successfully) is not noted. Considering that a large 
part of the variance of alexithymia could not be reached, the most likely 
solution is to make a more explicit operational definition of EOCS or EOT. 
Although a positive outcome has not been specified for this dimension in 
the criterion-related validity study, it is understood that a hint has been 
captured for better understanding of the subject. The content of this con-
struct or factor should be better defined and then measuring procedures 
should be performed at a better level.
A similar result is also noted in two-factor solutions. While EC of the A 
Alexithymia Scale shows high correlation coefficients with the TS and both 
with DIF and DDF of TAS-20. Thus, EC yielded a low correlation with EOT 
(cognitive component of construct). Nevertheless, correlation coefficients 
between 0.34 and 0.47 have been calculated between CC of A Alexithymia 
Scale and TS and dimensions of TAS-20. Instead of showing that CC of the 
scale developed in this study is not correlated with TAS-20, it seems that 
TAS-20 has been weak to reflect the CC of alexithymia compared to A 
Alexithymia Scale. Because the main similarity between the two scales is in 
the expression of feelings. The highest correlation coefficient between the 
TS of the A Alexithymia Scale and DDF dimension of TAS-20.
Another validity study is the discriminant validity study. The results of lon-
gitudinal studies conducted in groups of different natures and over differ-
ent periods showed that alexithymia was a personality trait (32,33,36). 
Alexithymia has been often associated with the constructs of 5FPI in pre-
vious studies; thus, it is important to associate the A Alexithymia Scale 
developed based on the trait approach with the constructs of this model. 
The expectation was that the correlation of the construct would be at 
a weak level not to overlap with personality traits and at a high level to 
reveal the relationship. The results were in the direction of expectations 
both in two- and five-factor solutions. Correlation coefficients between 
-0.29 and -0.35 were calculated for the TS of A Alexithymia Scale and 
the constructs of 5FPI. In a similar comparison study, correlation coef-
ficients between the TS of TAS-20 and the factors of NEO Personality 
Inventory were -0.25 for Extraversion, 0.03 for Agreeableness, -0.28 for 
Conscientiousness, 0.42 for Emotional Stability, and -0.38 for Openness to 
Experience (83). Considering the qualitative difference in the participating 
groups, the results of this study and the results mentioned above are quite 
similar, except for the Agreeableness factor.
Although A2, due to its participant characteristics, was more homoge-
neous than A1 and that no significant differences were seen in the results 
of EFA, CFA and internal validity in a sense with repetitive results con-
tributed to the validity of the scale. However, the lack of the number of 
participants in different groups in A2 for criterion-related validity (n=48) 
and for test-retest reliability (n=50) and participants not being balanced 
in the whole study was a limitation of the study. In the context of the 
specified studies, it could be useful to be repeated with larger participant 
groups. The scale to be tested in different groups and the creation of cut 
scores are observed as the features that can contribute to the validity of 
the scale in future research.
Measuring instruments differ from each other whether they fulfill the 
technical requirements or not, such as the features of being easily ac-
cessible, easy-to-use and understandable, and having strong psychomet-
ric properties. Although it is clear that the scale developed in this study 
should be supported with other validity findings, it is shown that the scale 
carries basic psychometric properties that can be used in studies on the 
subject. When the A Alexithymia Scale developed is evaluated in terms 
of the presented results, it appears that it can be considered as an alter-
native to the existing scales and be used in the studies on the subject. The 
scale seems to be more advantageous for reasons, such as having a higher 
percentage of explanation than similar scales, showing higher reliability 
coefficients, having multidimensional structure, and cognitive component, 
as well as emotional component included at the same ratio. It is believed 
that the use of this scale will be of practical benefit that it will give more 
powerful/reliable results and provide more detailed information.
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